Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.
about
Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitorTime effects of food intake on the pharmacokinetics and pharmacodynamics of quazepamAvailability of polychlorinated biphenyls (PCBs) and lindane for uptake by intestinal Caco-2 cells.Absorption-Enhancing Effects of Bile SaltsReduced-fat foods: the complex science of developing diet-based strategies for tackling overweight and obesityDipyridamole bioavailability in subjects with reduced gastric acidityOral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in miceThe role of oral controlled release matrix tablets in drug delivery systemsHeterologous Expression and Delivery of Biologically Active Exendin-4 by Lactobacillus paracasei L14Simulation-based cheminformatic analysis of organelle-targeted molecules: lysosomotropic monobasic amines.Effect of Food on the Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237) in Patients with Advanced Solid Tumors.Impact of food, alcohol and pH on modified-release hydrocortisone developed to treat congenital adrenal hyperplasiaImproving In Vivo Efficacy of Bioactive Molecules: An Overview of Potentially Antitumor Phytochemicals and Currently Available Lipid-Based Delivery Systems.Modes of Disintegration of Solid Foods in Simulated Gastric Environment.The role of small-intestinal P450 enzymes in protection against systemic exposure of orally administered benzo[a]pyreneUltrafast surface hydration dynamics and expression of protein functionality: alpha -Chymotrypsin.Lipid-based formulations for oral administration: opportunities for bioavailability enhancement and lipoprotein targeting of lipophilic drugs.Mobilization of soil-bound residue of organochlorine pesticides and polycyclic aromatic hydrocarbons in an in vitro gastrointestinal modelPharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects.Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.Islamic fasting and multiple sclerosis.A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumorsApplications of human pharmacokinetic prediction in first-in-human dose estimationGastroretentive delivery systems: a mini review.The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension.Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.Cocrystal Solubilization in Biorelevant Media and its Prediction from Drug SolubilizationImpact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans.Effects of food on the relative bioavailability of lapatinib in cancer patients.Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.Synthesis of Mg-Fe-Cl hydrotalcite-like nanoplatelets as an oral phosphate binder: evaluations of phosphorus intercalation activity and cellular cytotoxicity.Mechanism-Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake.From bench to humans: formulation development of a poorly water soluble drug to mitigate food effectBiomagnetic methods: technologies applied to pharmaceutical research.Effects of surfactants on lipase structure, activity, and inhibition.Functions of lipids for enhancement of oral bioavailability of poorly water-soluble drugs.Nanostructured lipid carriers system: recent advances in drug delivery.Assessing the bioavailability and bioaccessibility of metals and metalloids.Utilizing food effects to overcome challenges in delivery of lipophilic bioactives: structural design of medical and functional foods.Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.
P2860
Q24656105-6039E364-5332-42A8-8D79-06236A2F8B5FQ24679467-D57B9AB0-40FC-4111-A78D-FE396EA04605Q24812807-A8F4E4C0-BBCC-46C1-AA8C-95907F2CEAC1Q26798510-0E35FE10-7F1A-4FCC-BB0B-4AD0099236AFQ27003112-A9FB2518-BF49-41FC-B53D-708A7D2DA35BQ28177095-70359B34-EA1F-4F35-BF25-413D615894B0Q28218674-96FC094B-BB37-4EA8-87CD-ABCE291FB83EQ28290739-ABC142AF-6A1E-4A22-830D-51B9223ECDECQ28552845-87E1F85F-C974-4740-9E72-4ED88862CB38Q33323615-3F8528FF-0B66-441D-AF53-9CF41D0C061BQ33428581-FE0D5E90-246B-4181-B097-1D1D22C97F98Q33659999-36232FAF-2D5E-4483-9BF3-D10E72F7A508Q33710442-CF70D1C4-57ED-4112-BA76-6B63A58883A2Q33789313-DAC1A46E-D46A-4D92-8BEE-E84689E6CE5DQ34028109-3C77303B-2196-4F1C-948F-FBD95B24C818Q34385481-BCA2EB3F-D5FF-4396-A5DB-1A6B3C6130E1Q34470793-848B8C5E-5D59-4C0B-98CD-DA6C6C3C5622Q34543212-02ABEEBB-6BC8-4AF9-B25C-1008BA672C00Q34635528-1A80A727-BA0E-423E-BE82-854FBDD6BD40Q34733880-8A7AE172-0C27-485C-9DB0-1921B2AF5E66Q35127335-99458206-5981-409D-A87D-AED1F9854051Q35563528-C4870750-1C4C-408E-B271-93229FC4330EQ35888391-BB976E3B-7C13-4F29-900B-9ADF989A6CA8Q35982044-3A1A6AE4-1AFF-416A-89AE-0E62F685C0BCQ36088451-2E369C66-D710-4E73-98CD-EA0C6BD4ED8CQ36303746-23683520-9BA2-4B9E-B846-97814AA621D2Q36446679-6AD4C515-7855-480D-88A9-9E50212AA29AQ36909306-CC3E9DDF-7BFD-494D-A8C1-DB5A6E73B837Q36938561-F29ACAC1-5BAF-4595-B107-9B6AB57B46BBQ37058658-C049D47C-3103-48FB-BAE4-029BA66D2298Q37223466-CF80CC98-E2EF-473C-8E7B-1516966DDFC0Q37540015-8B7792CC-B5B2-4186-BCCB-CD04098D0017Q37671854-804DA294-8520-40DC-BDBC-D78DD4FF7531Q37800414-66F5AFD6-B76A-4C7E-BA0C-C68AFC70B109Q37828446-1D92A000-5964-4852-8BB2-398FA147D087Q37965173-1EA4842F-C804-4AFB-A3BA-254103643408Q38038902-A0EC95D1-21A3-4A13-8CC1-6A21B9B36FCDQ38114325-B7BCAD70-E13E-4301-8728-C51213FBB7A4Q38140095-2DE0E939-7964-4225-BFF8-E888C1895CD8Q38199540-707DCFDA-FE65-43C4-BC17-05A593877E31
P2860
Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Physiochemical and physiologic ...... on: the role of lipids and pH.
@en
type
label
Physiochemical and physiologic ...... on: the role of lipids and pH.
@en
prefLabel
Physiochemical and physiologic ...... on: the role of lipids and pH.
@en
P2093
P356
P1476
Physiochemical and physiologic ...... on: the role of lipids and pH.
@en
P2093
Charman WN
Dressman JB
P304
P356
10.1021/JS960085V
P407
P577
1997-03-01T00:00:00Z